Plain-English translation of NCT07751159 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two different ways of delivering radiation therapy to treat high-risk prostate cancer. Some men will receive a combination of two radiation approaches (brachytherapy boost plus SBRT), while others will receive SBRT alone. The goal is to find which approach best controls cancer while keeping side effects manageable and protecting quality of life.
Doctors want to find the most effective radiation therapy plan for men with aggressive prostate cancer—one that fights the cancer effectively without causing too many unwanted side effects. This trial will help determine whether combining two radiation methods works better than using one approach alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either a combination of two radiation therapies or one radiation therapy alone. Your treatment team will deliver the radiation according to your assigned group, with regular follow-up appointments to monitor how well the treatment is working and track any side effects. The study involves 126 men total and is being conducted at Memorial Sloan Kettering Cancer Center.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States